BioSpace News Archive

No longer on the periphery of the life sciences market, nonprofit groups are bridging the gaps in drug discovery and development.

Following the J.P. Morgan Healthcare Conference and other parallel meetings in San Francisco, it’s time to reflect on some of the significant deals secured last week.

Medivir AB announced that clinical pharmacokinetic data from the first study with fostroxacitabine bralpamide will be presented at the European Association for the Study of the Liver Liver Cancer Summit in February 22-24, 2024 in Rotterdam.

Theralase Technologies Inc. is providing an update regarding its Phase II Non-Muscle Invasive Bladder Cancer (" NMIBC ") clinical study (" Study II ").

Florida Cancer Specialists & Research Institute, LLC is pleased to announce the appointments of Joel Grossman, MD and Maen Hussein, MD to its Executive Board.

Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V., announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. Nordic Pharma recently expanded its pharmaceutical expertise in the U.S. by acquiring Visant Medical, Inc., a leader in medical technology innovation in Dry Eye Disease.

AB Science SA (Euronext - FR0010557264 - AB) today announced that the European Patent Office has issued a Notice of Allowance for a patent relating to methods of treating severe systemic mastocytosis (i.e. a medical use patent) with its lead compound masitinib, based on findings from study AB06006 [1].

Brain Navi announced the completion of the 100th case utilizing its neurosurgical navigation robot NaoTrac.

The Bill & Melinda Gates Foundation announced its largest annual budget to date as it works toward the goal of a healthier, more prosperous world for all.

Basilea Pharmaceutica Ltd announced that it has entered into an asset purchase agreement with Spexis AG for a preclinical program of antibiotics from a novel class, targeting Gram-negative bacteria, including multidrug-resistant strains.